Birmingham Review Course 2024 | Coronary Artery Revascularization: Trials Update

Currently in its 32nd year, the Birmingham Review Course is the longest-running course in the cardiothoracic specialty. The 2025 course promises an immersive learning experience featuring didactic lectures and interactive seminars on cardiac and thoracic topics, along with opportunities to engage with an international faculty. The 2025 Birmingham Review Course will take place from September 11–13, 2025. 

At the 2024 Birmingham Review Course, Professor Mahmoud Loubani, a consultant cardiothoracic surgeon at Hull University Teaching Hospitals NHS Trust, delivered a presentation titled “Coronary Artery Revascularization: Trials Update.”  

In his presentation, he discussed several trials, including the STICH trial, SYNTAX trial and score, and the Noble trial, which compared coronary artery bypass grafting (CABG) with biolimus-eluting stent (BES) in 2016. He also examined coronary artery bypass surgery in patients with left ventricular dysfunction, CABG in stable coronary multivessel disease, the evidence for leiomyosarcoma (LMS) disease, CABG in patients with diabetes mellitus (DM), and the severity of coronary artery disease. 

Disclaimer

The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.